{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:03:13Z","timestamp":1791946993618,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"am","delay-in-days":390,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vaccine.2023.06.076","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T07:34:36Z","timestamp":1688196876000},"page":"4907-4917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Generation and characterization of a genetically modified live rabies vaccine strain with attenuating mutations in multiple viral proteins and evaluation of its potency in dogs"],"prefix":"10.1016","volume":"41","author":[{"given":"Fumiki","family":"Izumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoya","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Masatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1607-2175","authenticated-orcid":false,"given":"Michihito","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4613-7232","authenticated-orcid":false,"given":"Yuji","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misuzu","family":"Okajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0296-966X","authenticated-orcid":false,"given":"Naoto","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.06.076_b0005","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.06.076_b0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3201\/eid0104.950401","article-title":"The ascension of wildlife rabies: a cause for public health concern or intervention?","volume":"1","author":"Rupprecht","year":"1995","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.076_b0015","series-title":"WHO Expert Consultation on Rabies","first-page":"78","article-title":"Prevention and control of rabies in dogs","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.vaccine.2023.06.076_b0020","volume":"7","author":"Rabies has its day","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.076_b0025","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(08)61462-2","article-title":"The global fight against rabies","volume":"372","author":"Burki","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.06.076_b0030","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7774\/cevr.2014.3.2.176","article-title":"A single immunization with recombinant rabies virus (ERAG3G) confers complete protection against rabies in mice","volume":"3","author":"Yang","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2023.06.076_b0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-014-0077-8","article-title":"Twenty year experience of the oral rabies vaccine SAG2 in wildlife: a global review","volume":"45","author":"M\u00e4hl","year":"2014","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2023.06.076_b0040","first-page":"185","article-title":"Elimination of terrestrial rabies in Western European countries","volume":"119","author":"Cliquet","year":"2004","journal-title":"Dev Biol"},{"key":"10.1016\/j.vaccine.2023.06.076_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003953","article-title":"Spatio-temporal use of oral rabies vaccines in fox rabies elimination programmes in Europe","volume":"9","author":"M\u00fcller","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.06.076_b0050","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2460\/javma.1982.180.11.1336","article-title":"Vaccine-induced rabies in four cats","volume":"180","author":"Esh","year":"1982","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2023.06.076_b0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2460\/javma.1984.185.03.285","article-title":"Use of monoclonal antibodies to confirm vaccine-induced rabies in ten dogs, two cats, and one fox","volume":"185","author":"Whetstone","year":"1984","journal-title":"J Am Vet Med Assoc"},{"issue":"997\u20138","key":"10.1016\/j.vaccine.2023.06.076_b0060","article-title":"Rabies induced in a cat by high-egg-passage Flury strain vaccine","volume":"183","author":"Bellinger","year":"1983","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2023.06.076_b0065","first-page":"105","article-title":"Vaccine-induced rabies infection in rural dogs in Anambra State","volume":"57","author":"Okolo","year":"1989","journal-title":"Nigeria Microbios"},{"key":"10.1016\/j.vaccine.2023.06.076_b0070","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"Schnell","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2023.06.076_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2018.00091","article-title":"In vivo safety studies with SPBN GASGAS in the frame of oral vaccination of foxes and raccoon dogs against rabies","volume":"5","author":"Ortmann","year":"2018","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2023.06.076_b0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2015.06.011","article-title":"Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination","volume":"121","author":"Shuai","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2023.06.076_b0085","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1016\/j.vaccine.2012.03.044","article-title":"Generation of a live rabies vaccine strain attenuated by multiple mutations and evaluation of its safety and efficacy","volume":"30","author":"Nakagawa","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.076_b0090","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1016\/j.vaccine.2017.08.050","article-title":"Generation of a novel live rabies vaccine strain with a high level of safety by introducing attenuating mutations in the nucleoprotein and glycoprotein","volume":"35","author":"Nakagawa","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.076_b0095","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/JVI.76.7.3374-3381.2002","article-title":"Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response","volume":"76","author":"Faber","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.06.076_b0100","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.77.1.237-244.2003","article-title":"Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic","volume":"77","author":"McGettigan","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.06.076_b0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0264-410X(94)90095-7","article-title":"Vaccination against rabies: construction and characterization of SAG2, a double avirulent derivative of SADBern","volume":"12","author":"Lafay","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.076_b0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0042-6822(89)90122-0","article-title":"Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice","volume":"172","author":"Tuffereau","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2023.06.076_b0115","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1016\/j.vaccine.2021.05.002","article-title":"Safety enhancement of a genetically modified live rabies vaccine strain by introducing an attenuating Leu residue at position 333 in the glycoprotein","volume":"39","author":"Ito","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.076_b0120","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.vaccine.2004.06.031","article-title":"In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife","volume":"23","author":"Dietzschold","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.076_b0125","doi-asserted-by":"crossref","first-page":"14141","DOI":"10.1128\/JVI.79.22.14141-14148.2005","article-title":"A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity","volume":"79","author":"Faber","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.06.076_b0130","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1073\/pnas.0905640106","article-title":"Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus","volume":"106","author":"Faber","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2023.06.076_b0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.7774\/cevr.2016.5.2.159","article-title":"Safety and immunogenicity of recombinant rabies virus (ERAGS) in mice and raccoon dogs","volume":"5","author":"Yang","year":"2016","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2023.06.076_b0140","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1128\/JVI.02220-09","article-title":"Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response","volume":"84","author":"Masatani","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.06.076_b0145","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.virusres.2010.09.016","article-title":"Amino acids at positions 273 and 394 in rabies virus nucleoprotein are important for both evasion of host RIG-I-mediated antiviral response and pathogenicity","volume":"155","author":"Masatani","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2023.06.076_b0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0012-1606(74)80027-8","article-title":"Expression of neuronal phenotypes in neuroblastoma cell hybrids","volume":"39","author":"McMorris","year":"1974","journal-title":"Dev Biol"},{"key":"10.1016\/j.vaccine.2023.06.076_b0155","unstructured":"World Organisation for Animal Health. Rabies (infection with rabies virus and other lyssaviruses) In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals; 2018, p. 578\u2013614."},{"key":"10.1016\/j.vaccine.2023.06.076_b0160","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1348-0421.1985.tb00884.x","article-title":"Virulence of chick embryo fibroblast-passaged flury HEP rabies virus and its revertants in mice","volume":"29","author":"Arai","year":"1985","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2023.06.076_b0165","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1126\/science.628831","article-title":"Rabies viruses increase in virulence when propagated in neuroblastoma cell culture","volume":"199","author":"Clark","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.06.076_b0170","series-title":"WHO Expert Consultation on Rabies","first-page":"57","article-title":"Prevention of human rabies","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.vaccine.2023.06.076_b0175","series-title":"Rabies","first-page":"347","article-title":"Pathology","author":"Rossiter","year":"2020"},{"key":"10.1016\/j.vaccine.2023.06.076_b0180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/dnares\/dsu029","article-title":"The genome landscape of the african green monkey kidney-derived vero cell line","volume":"21","author":"Osada","year":"2014","journal-title":"DNA Res"},{"key":"10.1016\/j.vaccine.2023.06.076_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/v12090914","article-title":"Genetic and phenotypic characterization of a rabies virus strain isolated from a dog in Tokyo, Japan in the 1940s","author":"Takahashi","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2023.06.076_b0190","unstructured":"World Organisation for Animal Health. First oral rabies vaccine for dogs, https:\/\/bulletin.woah.org\/?p=24075; 2023 [accessed 14 April 2023]."},{"key":"10.1016\/j.vaccine.2023.06.076_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11020307","article-title":"Efficacy of oral rabies vaccine baits containing SPBN GASGAS in domestic dogs according to international standards","author":"Bobe","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.06.076_b0200","first-page":"8","article-title":"Humoral immune response of Thai dogs after oral vaccination against rabies with the SPBN GASGAS vaccine strain","author":"Leelahapongsathon","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.06.076_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.737250","article-title":"Immunogenicity of the oral rabies vaccine strain SPBN GASGAS in dogs under field settings in Namibia","volume":"8","author":"Molini","year":"2021","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2023.06.076_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/v13040571","article-title":"Feasibility and effectiveness studies with oral vaccination of free-roaming dogs against rabies in Thailand","author":"Chanachai","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2023.06.076_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010422","article-title":"Oral rabies vaccination of dogs-Experiences from a field trial in Namibia","volume":"16","author":"Freuling","year":"2022","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2300779X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2300779X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:28:14Z","timestamp":1759404494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2300779X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":43,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0264410X2300779X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.076","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and characterization of a genetically modified live rabies vaccine strain with attenuating mutations in multiple viral proteins and evaluation of its potency in dogs","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}